Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/J2top.php on line 78
Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination - PharmaFacts
gototopgototop
If you don't find what you're looking for, please let us know.

Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/modulesanywhere.php on line 159

Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination

Guidances - FDA Guidances

Draft Guidance- Not for implementation- December 2010

This guidance is intended to assist sponsors in the codevelopment of two or more novel (not previously marketed) drugs to be used in combination to treat a disease or condition.  The guidance provides recommendations and advice on how to address certain scientific and regulatory issues that will arise during codevelopment.  It is not intended to apply to development of fixed-dose combinations of already marketed drugs or to development of a single new investigational drug to be used in combination with an approved drug or drugs.  The guidance is also not intended to apply to vaccines, gene or cellular therapies, blood products, or medical devices.

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM236669.pdf